DFDA

Beta-blockers (e.g., Metoprolol, Propranolol)

Treatment for Hypertrophic Cardiomyopathy

Typical Dosage: Metoprolol succinate 25-200mg daily

Effectiveness
65%
Safety Score
70%
Clinical Trials
500
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠ī¸
Meth💀
CigarettesđŸšŦ
Chemoâ˜ĸī¸
AlcoholđŸē
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
Metoprolol succinate 25-200mg daily
Time to Effect
Hours to days
Treatment Duration
Lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75
Monitoring:$400
Side Effect Mgmt:$75
Total Annual:$550
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
5
Outcome-Based Costs
Cost per Responder
$846
Prescription Access Economics
Risk Assessment
Requires Monitoring
Yes
Needs lab work/checkups
Beta-blockers (e.g., Metoprolol, Propranolol) Outcomes

for Hypertrophic Cardiomyopathy

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+65%
Common Side Effects
Fatigue
+15%
Bradycardia
+8%
Hypotension
+7%
Dizziness
+7%
Exacerbation of asthma/COPD
+2%

Sources:

bmj.com
nih.gov
researchgate.net

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov